Latest filing published 13 Aug 2026 for ICU Medical Inc/de, €852k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Woolson, listed as chief executive, appears in our data through filings on ICU Medical Inc/de shares, published by SEC (Form 4). Between 6 March 2022 and 13 August 2026, the trades on record add up to 15 filings.
No open-market purchase appears, only 7 sales worth €2.5M. Outside the open market, there are 8 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 13 August 2026 with an open-market sale (€852k) in ICU Medical Inc/de. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations